Novartis AG is 145.1x more valuable than Bausch Health Companies Inc. by market capitalization ($283.13 B vs $1.95 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BHC | NVS |
|---|---|---|
| Market cap | $1.95 B | $283.13 B |
| US-listed rank | #2112 | #47 |
| Revenue (latest FY) | $10.27B | - |
| Net income (latest FY) | $157.00M | - |
| Net margin | 1.5% | - |
| P/E (trailing FY) | 12.4 | - |
| SEC filings | 2,398 | 947 |
Novartis AG is 145.1x more valuable than Bausch Health Companies Inc. by market capitalization ($283.13 B vs $1.95 B).
Full pages: Bausch Health Companies Inc. and Novartis AG, or browse the full rankings.